ALGN vs XLO · P/E 35, rev $2.10B vs rev $31.3M
Align Technology Inc (ALGN) versus Xilio Development Inc (XLO) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
Xilio Development Inc (XLO) is a biotechnology company listed on NASDAQ.
Latest reported ALGN revenue for 2026-06-30 was $2.10B. Net income was $221.1M. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
Latest reported XLO revenue for 2026-06-30 was $31.3M. Net income was -$15.9M. XLO currently screens at market cap $55.3M.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. XLO currently screens at market cap $55.3M.
Not investment advice. Open the ALGN and XLO stock pages for the full models.
Not investment advice.